Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 6284   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 2001  |  Volume : 19  |  Issue : 2  |  Page : 9-15

Assessment And Comparison Of Quality Of In COPD Patients Received Ipratropium And Sustaine Release Theophylline



Correspondence Address:
P. A Mahesh


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Introduction: Chronic Obstructive Pulmonary disease is commonly prevalent disease with high level of disability. The goals of treatment are only palliative and to improve the quality of life of these patients. Health related quality of life instruments are useful in monitoring the patient’s progress and in identifying the appropriate treatment and provide information complimentary to pulmonary function tests. They are now regularly used in assessing any new intervention in COPD patient’s in western studies. There are limited data available regarding the changes in health status after treatment in COPD patient’s in our country. Hence this study was undertaken. Objectives: (1) To assess and compare the quality of life in COPD patients receiving ipratropium bromide or sustained release Theophylline or both. (2) To translate and validate the disease specific St. Georg’s Respiratory Questionnaire into the local language. Study Population: Thirty – five patients with stable COPD attending the outpatient clinic Design: Cross over trial. Methodology: Patients with COPD satisfying the including criteria were recruited into the study. After baseline Spirometry, the St. Georg’s Respiratory Questionnaire, Baseline dyspnea index, Modified Borg’s dyspnea scale were administered. These were repeated during follow up every 15 days and patients received ipratropium and theophylline for one month each followed by a combination of ipratropium and theophylline.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed307    
    Printed19    
    Emailed0    
    PDF Downloaded90    
    Comments [Add]    

Recommend this journal